Skip to content

Effects of Inulin on Satiety and Food Intake

Effects of Inulin on Satiety and Food Intake

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01025375
Acronym
Inulin
Enrollment
30
Registered
2009-12-03
Start date
2009-01-31
Completion date
2010-02-28
Last updated
2012-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

overweight

Brief summary

To assess the effect of inulin on appetite profile ratings, food intake and satiety hormones.

Detailed description

Based upon a slower digestion and the fermentation in the intestinal tract, food containing soluble dietary fibres, such as inulin, is hypothesized to be more satiating, and to limit energy intake, in humans. Does supplementation of inulin (at 2 dosages) versus placebo over 13 consecutive days in normal to overweight men and women, lead to an increase in satiety, a reduction in food intake and stronger postprandial increases in GLP-1 and PYY?

Interventions

DIETARY_SUPPLEMENTinulin

10gram/day inulin for 13-day treatment

DIETARY_SUPPLEMENTplacebo

16gram/day maltodextrin (placebo) for 13-day treatment

Sponsors

Maastricht University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* age between 18 and 60 years * BMI between 23 and 28 kg/m2 * dietary unrestraint (TFEQ: F1\<9)

Exclusion criteria

* age under 18 and above 60 years * BMI under 23 and above 28 kg/m2 * dietary restraint (TFEQ: F1\>9) * use of medication * pregnant or breastfeeding

Design outcomes

Primary

MeasureTime frame
food intakeon testday 0 and 13

Secondary

MeasureTime frame
appetite profile ratingson test day 0, 8 and 13 (at 16 time points)
satiety hormones (GLP-1 and PYY)on test day 0 and 13 (at 9 time points

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026